WHO ICTRP trial
A prospective study of rivaroxaban in the prevention of PICC related thrombosis…
ChiCTR-IIR-17011109 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR-IIR-17011109 |
|---|---|
| Public title | A prospective study of rivaroxaban in the prevention of PICC related thrombosis in cancer patients |
| Scientific title | A prospective study of rivaroxaban in the prevention of PICC related thrombosis in cancer patients |
| Primary sponsor | Sun Yat-sen University Cancer Center |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | III (Phase III study) |
| Countries | China |
| Conditions | Venous thromboembolism |
| Interventions | Rivaroxaban+ conventional nursing group:Rivaroxaban+ conventional nursing;Conventional nursing group:Conventional nursing |
| Registration date | Apr 10, 2017 |
| Target size | Rivaroxaban+ conventional nursing group:150;Conventional nursing group:150 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: